real-world

Open Access
Real-world Efficacy and Safety of Bevacizumab for Advanced or Recurrent Müllerian Cancer: A Single-institutional Experience
TAKESHI FUKUDA, TAKUYA NODA, EIJIRO UCHIKURA, YUICHIRO AWAZU, REIKO TASAKA, KENJI IMAI, MAKOTO YAMAUCHI, TOMOYUKI ICHIMURA, TOMOYO YASUI and TOSHIYUKI SUMI

Anticancer Research July 2023, 43 (7) 3097-3105; DOI: https://doi.org/10.21873/anticanres.16481
You have access
Recurrence-free Survival and Safety of Imatinib in Patients With Gastrointestinal Stromal Tumour (GIST) in Greece
IOANNIS BOUKOVINAS, ATHANASIOS KOTSAKIS, NIKOLAOS ANDROULAKIS, GERASIMOS ARAVANTINOS, VASILIKI MICHALAKI, CHRISTOS CHRISTODOULOU, ANTONIOS AVGERINOS, CHRISTOS PAPANDREOU, VASILIKI SIDIROPOULOU, OLGA KOUSIDOU and PARIS KOSMIDIS

Anticancer Research January 2020, 40 (1) 435-441; DOI: https://doi.org/10.21873/anticanres.13971
You have access
Daratumumab Monotherapy in Heavily Pretreated Asian Patients With Relapsed and Refractory Multiple Myeloma: A Real-world Experience
JA MIN BYUN, SUNG-SOO YOON, YOUNGIL KOH, INHO KIM, JAEMIN JO, HYUNKYUNG PARK, JEONG-OK LEE and JIYUN LEE

Anticancer Research September 2019, 39 (9) 5165-5170; DOI: https://doi.org/10.21873/anticanres.13712

Main menu